Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,338 public trials 427 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Recruiting

Measuring Surgical Recovery After Radical Cystectomy

NCT03193970

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Stanford University Stanford, California, United States
  • Emory University Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • University of Kansas Medical Center Lawrence, Kansas, United States
View Trial Details
Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

NCT07097142

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
Locations
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 211 locations
View Trial Details
Recruiting

A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection

NCT06011954

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Site KR82001 Goyang-si, Gyeonggi-do, South Korea
  • Site KR82012 Suwon, Gyeonggi-do, South Korea
  • Site KR82008 Suwon, Gyeonggi-do, South Korea
  • Site KR82007 Jeollanam-do, South Korea
View all 18 locations
View Trial Details
Recruiting

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

NCT07421700

Conditions
Advanced/Metastatic Urothelial Cancer, Carcinoma, Carcinoma, Transitional Cell, +15 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • Highlands Oncology Group, PA Rogers, Arkansas, United States
  • Highlands Oncology Group, PA Springdale, Arkansas, United States
  • UCLA Hematology/Oncology - Alhambra Alhambra, California, United States
View all 153 locations
View Trial Details
Recruiting

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

NCT05126472

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer

NCT07187635

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Nanchang Second People's Hospital Nanchang, Anhui, China
  • Sun Yat-sen Memorial Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
  • Xingtai People's Hospital Xingtai, Hebei, China
  • The Second Affiliated Hospital of Kunming Medical University Kunming, Yunnan, China
View Trial Details

Related conditions